The role of calpains in traumatic brain injury

Brain Injury

Volumn 28, Issue 2, 2014, Pages 133-137

  Liu, Shuang ^a   Yin, Feng ^a   Zhang, Jianning ^a   Qian, Yangming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biomarker; Calpains; Neuroprotection; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; CALPAIN;

HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; CALCIUM-BINDING PROTEINS; CALPAIN; CELL DEATH; CEREBRAL CORTEX; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; MALE; MICE; PROGNOSIS; PROTEOLYSIS; TREATMENT OUTCOME;

EID: 84893067768     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2013.860479     Document Type: Review

References (55)

1. Finnie JW, Blumbergs PC. Traumatic brain injury. Veterinary Pathology 2002;39:679-689
2. Reilly PL. Brain injury: The pathophysiology of the first hours. 'Talk and Die revisited'. Journal of Clinical Neuroscience 2001;8: 398-403
3. Wennersten A, Holmin S, Mathiesen T. Characterization of Bax and Bcl-2 in apoptosis after experimental traumatic brain injury in the rat. Acta Neuropathologica 2003;105:281-288
4. Moppett IK. Traumatic brain injury: Assessment, resuscitation and early management. British Journal of Anaesthesia 2007;99: 18-31
5. Finnie JW. Neuroinflammation: Beneficial and detrimental effects after traumatic brain injury. Inflammopharmacology 2013;8: Epub ahead of print
6. Jaskova K, Pavlovicova M, Jurkovicova D. Calcium transporters and their role in the development of neuronal disease and neuronal damage. General Physiology and Biophysics 2012;31:375-382
7. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? Journal of Neuroscience Research 2005;79:231-239
8. Rego AC, Monteiro NM, Silva AP, Gil J, Malva JO, Oliveira CR. Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures. Journal of Neurochemistry 2003;86:792-804
9. Czogalla A, Sikorski AF. Spectrin and calpain: A 'target' and a 'sniper' in the pathology of neuronal cells. Cellular and Molecular Life Science 2005;62:1913-1924
10. Golstein P, Kroemer G. A multiplicity of cell death pathways. Symposium on apoptotic and non-Apoptotic cell death pathways. EMBO Reports 2007;8:829-833
11. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Progress in Neurobiology 2000;62:273-295
12. Asah M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia, effects of gene knockout and enzyme inhibition with BB-94. Journal of Cerebral Blood Flow - Metabolism 2000;20:1681-1689
13. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: A brief overview. Journal of Head Trauma Rehabilitation 2006;21:375-378
14. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: Pathomechanisms and treatment strategies. Progress in Brain Research 2007;161:125-141
15. Farkas O, Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic brain injury: A complex web of change extending far beyond focal damage. Progress in Brain Research 2007;161: 43-59
16. Vanderklish PW, Bahr BA. The pathogenic activation of calpain: A marker and mediator of cellular toxicity and disease states. International Journal of Experimental Pathology 2000;81:323-339
17. Liu J, Liu MC, Wang KK. Calpain in the CNS: From synaptic function to neurotoxicity. Science Signaling 2008;1:tr3
18. Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, Mclntosh TK. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. Journal of Neuropathology & Experimental Neurology 1996;55: 850-860
19. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC. Calpain as a novel target for treating acute neurodegenerative disorders. Neurological Research 1995;17: 249-258
20. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL. Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy: Implications for pathology and therapy: A review and update. Journal of Neurotrauma 1997;14:121-134
21. Bralic M, Stemberga V. Calpain expression in the brain cortex after traumatic brain injury. Collegium Antropologicum 2012;36: 1319-1323
22. Saatman KE, Creed J, Raghupathi R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 2010;7:31-42
23. Zhang Z, Larner SF, Liu MC, Zheng W, Hayes RL, Wang KK. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways. Apoptosis 2009;14:1289-1298
24. Aikman J, O'Steen B, Silver X, Torres R, Boslaugh S, Blackband S, Padgett K, Wang KKW, Hayes R, Pineda J. Alpha-II-spectrin after controlled cortial impact in the immature rat brain. Developmental Neuroscience 2006;28:457-465
25. Pineda JA, Wang KK, Hayes RL. Biomarkers of proteolytic damage following traumatic brain injury. Brain Pathology 2004;14: 202-209
26. Brophy GM, Pineda JA, Papa L, Lewis SB, Valadka AB, Hannay JH, Heaton SC, Demery JA, Liu MC, Tepas III JJ, et al. Alpha IIspectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. Journal of Neurotrauma 2009;26:471-479
27. Mondello S, Robicsek SA, Gabrielli A, Brophy GM, Papa L, Tepas III J, Robertson C, Buki A, Scharf D, Jixiang M, et al. Alpha IIspectrin breakdown products(SBDPs): Diagnosis and outcome in severe traumatic brain injury patients. Journal of Neurotrama 2010; 27:1203-1213
28. Wang KK, Villalobo A, Roufogalis BD. Calmodulin-binding proteins as calpain substyates. Biochemistry & Cell Biology 1989;67:703-711
29. Mustafa AG, Wang JA, Carrico KM, Hall ED. Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury. Journal of Neurochemistry 2011;117:579-588
30. Ottens AK, Golden EC, Bustamante L, Hayes RL, Denslow ND, Wang KK. Proteolysis of multiple myelin basic protein isoforms after neurotrauma: Characterization by mass spectrometry. Journal of Neurochemistry 2008;104:1404-1414
31. Saatman KE, Feeko KJ, Pape RL, Raghupathi R. Differential behavioral and histopathological responses to graded cortical impact injury in mice. Journal of Neurotrauma 2006;23:1241-1253
32. Kathryn ES, David IG, Tracy KM. The neuronal cytoskeleton is at risk after mild and moderate brain injury. Journal of Neurotrama 1998;15:1047-1058
33. Sun FY, Faden AI. N-methyl-D-Aspartate receptors mediate posttraumatic increases of protein kinase C in rat brain. Brain Research 1994;66:63-69
34. Perri BR, Smith DH, Murai H, Sinson G, Saatman KE, Raghupathi R, Bartus RT, Mclntosh TK. Metabolic quantification of lesion volume following experimental traumatic brain injury in the rat. Journal of Neurotroma 1997;14:15-22
35. Pike BR, Zhao X, Newcomb JK, Glenn CC, Anderson DK, Hayes RL. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. Journal of Neurotrauma 2000;17:283-298
36. Newcomb JK, Kampfl A, Posmantur RM, Zhao X, Pike BR, Liu SJ, Clifton GL, Hayes RL. Immunohistochemical study of calpainmediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. Journal of Neurotrauma 1997;14:369-383
37. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL, Hayes RL. Mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. Journal of Neurochemistry 1996;67:1575-1583
38. Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, Roberts VL. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiology of Disease 2004;16: 311-320
39. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT, Workshop Scientific Team and Advisory Panel Members. Classification of traumatic brain injury for targeted therapies. Journal of Neurotrauma 2008;25:719-738
40. Farkas O, Polgar B, Szekeres-Bartho J, Doczi T, Povlishock JT, Buki A. Spectrin breakdown products in the cerebrospinal fluid in severe head injury-preliminary observations. Acta Neurochirurgica 2005;147:855-861
41. Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, et al. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. Journal of Neurotrauma 2007;24:354-366
42. Cardali S, Maugeri R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. Journal of Neurosurgical Sciences 2006;50:25-31
43. Zhang Z, Ottens AK, Shankar S, Kobeissy F, Tei F, Hayes RL, Wang KK. Calpain-mediated collapsin response mediator protein- 1, 2, and -4 proteolysis after neurotoxic and traumatic brain injury. Journal of Neurotrauma 2007;24:460-472
44. Kobeissy FH, Ottens AK, Zhang Z, Liu MC, Denslow ND, Dave JR, Tortella FC, Hayes RL, Wang KK. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Molecular & Cellular Proteomics 2006;5:1887-1898
45. McGinn MJ, Kelley BJ, Akinyi L, Oli MW, Liu MC, Hayes RL, Wang KK, Povlishock JT. Biochemical, structural, and biomarker evidence for calpain- mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion. Journal of Neuropathology & Experimental Neurology 2009;68:241-249
46. Pike BR, Flint J, Dutta S, Johnson E, Wang KK, Hayes RL. Accumulation of non-erythroid alpha II-spectrin and calpaincleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. Journal of Neurochemistry 2001;78:1297-1306
47. Huh JW, Franklin MA, Widing AG, Raghupathi R. Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats. Develomental Neuroscience 2006;28:466-476
48. Buki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. Journal of Neuropathology & Experimental Neurology 1999;58:365-375
49. Ringger NC, O'Steen BE, Brabham JG, Povlishock JT. A novel marker for traumatic brain injury: CSF alphaIIspectrin breakdown product levels. Journal of Neurotrauma 2004;21:1443-1456
50. Brophy GM, Pineda JA, Papa L, Lewis SB, Valadka AB, Hannay HJ, Heaton SC, Demery JA, Liu MC, Tepas JJ, et al. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. Journal of Neurotrauma 2009;26: 471-479
51. Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED. A pharmacological analysis of the neuroprotective efficacy of the brain- And cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. Journal of Neurotrauma. 2010;27:2233-2243
52. Schoch KM, Evans HN, Brelsfoard JM, Madathil SK, Takano J, Saido TC, Saatman KE. Calpastatin overexpression limits calpainmediated proteolysis and behavioral deficits following traumatic brain injury. Experimental Neurology 2012;236:371-382
53. Zhang M, Shan H, Gu Z, Wang D, Wang T, Wang Z, Tao L. Increased expression of calcium/calmodulin-dependent protein kinase type II subunit - After rat traumatic brain injury. Journal of Molelular Neuroscience 2012;46:631-643
54. Posmantur R, Kampfl A, Siman R, Liu J, Zhao X, Clifton GL, Hayes RL. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 1997;77:875-888
55. Ma M, Shofer FS, Neumar RW. Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury. Journal of Neurotrauma 2012;29:2555-2563